SINO BIOPHARMACEUTICAL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.77 HKD | +1.09% |
|
+18.38% | -20.17% |
| 04-25 | Sino Biopharm Completes Phase I Study of Hepatitis B Drug | MT |
| 04-22 | Lull in Geopolitical Tensions Lifts Asian Stock Markets | MT |
Chart calendar Sino Biopharmaceutical Limited
37.gb6jd9lVz0jaATvMQujrHNhOXbrRyaqrYnis5w1wrno.5vfqMKAeg3yWVQm5A92gZJc4ZdaAh9nPBB3mn1sIlhXk3Nsx9CSABONVVA~afc5ee19e5ebacd284d4297de329ccea
Upcoming events on Sino Biopharmaceutical Limited
Past events on Sino Biopharmaceutical Limited
| 27/03/2024 | Q4 2023 Earnings Release |
| 03/10/2023 | Ex-dividend day for dividende intermédiaire |
| 24/08/2023 | Q2 2023 Earnings Release |
| 01/08/2023 06:00 | Investor Day |
| 19/06/2023 | Final dividend |
| 08/05/2023 | Macquarie DELTAH China Conference |
| 30/03/2023 | Q4 2022 Earnings Release |
| 05/09/2022 | Ex-dividend day for dividende intermédiaire |
| 22/08/2022 | Interim 2022 Earnings Release |
| 14/06/2022 | Ex-dividend day for quarterly dividend |
| 09/06/2022 04:00 | Annual General Meeting |
| 30/03/2022 | FY 2021 Earnings Release |
| 12/09/2021 | Ex-dividend day for quarterly dividend |
| 30/08/2021 | Interim 2021 Earnings Release |
| 17/06/2021 | Ex-dividend day for quarterly dividend |
| 23/05/2021 | Q1 2021 Earnings Release |
| 22/03/2021 | FY 2020 Earnings Release |
| 10/12/2020 | Ex-dividend day for quarterly dividend |
| 29/11/2020 | Q3 2020 Earnings Release |
| 13/09/2020 | Ex-dividend day for quarterly dividend |
Past dividends on Sino Biopharmaceutical Limited
| 03/10/2023 | Interim Payment 0.02 HKD |
| 19/06/2023 | Final Payment 0.06 HKD |
| 05/09/2022 | Interim Payment 0.06 HKD |
| 14/06/2022 | Quarterly 0.04 HKD |
| 12/09/2021 | Quarterly 0.02 HKD |
| 17/06/2021 | Quarterly 0.02 HKD |
| 17/06/2021 | Quarterly 0.02 HKD |
| 10/12/2020 | Quarterly 0.02 HKD |
| 13/09/2020 | Quarterly 0.02 HKD |
| 11/06/2020 | Quarterly 0.02 HKD |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 20 889 20 502 1.89% | 24 234 25 208 -3.86% | 23 647 24 105 -1.9% | 26 861 27 804 -3.39% | 28 780 29 643 -2.91% | 26 199 30 237 -13.35% |
|
EBITDA Million CNY | Released Forecast Spread | 5 289 5 614 -5.78% | 6 399 6 760 -5.34% | 5 753 6 564 -12.35% | 5 174 6 880 -24.79% | 6 908 6 866 0.61% | 6 476 7 145 -9.36% |
|
EBIT Million CNY | Released Forecast Spread | 4 079 5 143 -20.68% | 4 840 5 537 -12.6% | 4 098 4 964 -17.44% | 4 182 5 621 -25.6% | 5 861 5 710 2.65% | 5 439 5 999 -9.32% |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 11 429 5 534 106.53% | 5 584 5 696 -1.97% | 5 013 5 226 -4.08% | 18 573 16 425 13.07% | 5 779 6 379 -9.42% | 5 215 5 990 -12.95% |
|
Net income Million CNY | Released Forecast Spread | 9 046 2 960 205.61% | 2 707 3 223 -16.03% | 2 771 2 755 0.6% | 14 608 12 921 13.06% | 2 544 3 698 -31.22% | 2 332 2 960 -21.21% |
|
EPS CNY | Released Forecast Spread | 0,49 0,16 205.86% | 0,14 0,17 -14.84% | 0,15 0,14 5.97% | 0,73 0,65 12.09% | 0,12 0,19 -37.35% | 0,13 0,15 -16.72% |
| Announcement Date | 31/03/19 | 30/03/20 | 23/03/21 | 31/03/22 | 31/03/23 | 28/03/24 |
Quarterly results
| Fiscal Period | December | 2019 S1 | 2020 S1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 12 527 12 600 -0.58% | 12 648 13 379 -5.47% | 7 111 7 370 -3.52% | 6 254 6 448 -3.02% | 6 254 6 192 0.99% | 15 194 15 020 1.15% | 13 587 15 188 -10.54% | 15 277 16 101 -5.12% | 10 922 14 927 -26.83% | 15 317 | 13 484 | 15 910 | 15 635 | ||
|
EBIT Million CNY | Released Forecast Spread | 2 417 2 470 -2.13% | 1 889 1 459 29.44% | 525 1 508 -65.18% | 525 942 -44.28% | 3 252 3 084 5.45% | 2 700 2 006 34.61% | 3 219 3 397 -5.24% | 2 220 2 465 -9.92% | 3 369 | 2 791 | 3 721 | 3 070 | |||
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 3 231 | 3 224 3 447 -6.46% | 1 991 2 671 -25.46% | ||||||||||||
|
Net income Million CNY | Released Forecast Spread | 1 642 | 1 259 2 297 -45.2% | 1 073 1 619 -33.71% | ||||||||||||
|
EPS CNY | Released Forecast Spread | 0,34 0,11 224.76% | 0,15 0,27 -43.4% | 0,15 0,12 30.43% | 0,05 0,09 -44.44% | 0,05 0,10 -50% | 0,09 0,11 -16.36% | 0,03 0,09 -67.22% | 0,07 0,09 -24.67% | 0,06 0,08 -27.38% | 0,08 | 0,06 | 0,09 | 0,09 | ||
| Announcement Date | 28/08/19 | 28/08/20 | 31/08/21 | 26/09/22 | 31/03/22 | 26/09/22 | 23/08/22 | 23/08/22 | 31/03/23 | 25/08/23 | 28/03/24 | - | - | - | - |
More events
Past sector events for Sino Biopharmaceutical Limited
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 1177 Stock
- Calendar Sino Biopharmaceutical Limited
